Endurant Capital Management LP Conmed Corp Transaction History

Endurant Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$77.7 - $112.82 $6.31 Million - $9.16 Million	-81,205 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$69.87 - $89.2 $5.67 Million - $7.24 Million	81,205 New	81,205 $6.39 Million
Q1 2020 May 15, 2020	SELL	$39.81 - $112.01 $714,191 - $2.01 Million	-17,940 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$93.31 - $116.55 $450,500 - $562,703	4,828 Added 36.82%	17,940 $2.01 Million
Q3 2019 Nov 14, 2019	BUY	$83.97 - $102.19 $1.1 Million - $1.34 Million	13,112 New	13,112 $1.26 Million

313

35.1M

95.6K

143K

Ticker CNMD
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 30,482,400
Market Cap $2.1B
Description
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.